The amount of boron accumulated in tumor tissue plays an important role regarding the success of the boron neutron capture therapy (BNCT). In this article, we report a modular system, combining readily available starting materials, like glycine, 1,3,5-triazine and the well-known 9-mercapto-1,7-dicarba-closo-dodecaborane(12), as well as á-d-galactopyranose for increased hydrophilicity, with a novel boron-rich tris-meta-carboranyl thiol.
Boron Boron Compounds